Autologous peripheral blood TILs therapy (Tianjin Medical University Cancer Institute And Hospital)

N/A

Report date: 2026/04/17 10:36:02

Base Information

Drug NameAutologous peripheral blood TILs therapy (Tianjin Medical University Cancer Institute And Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Tumor Infiltrating Lymphocytes
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesTianjin Medical University Cancer Institute And Hospital
China Registration ClassN/A

Develop Information

Active CompaniesThe General Hospital Of Tianjin Medical UniversityTianjin Medical University Cancer Institute And Hospital
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A